Indomethacin as a Rescue Therapy for Patent Ductus Arteriosus in Extremely Premature Infants after Failed Ibuprofen Treatment
<p dir="ltr">Hemodynamically significant patent ductus arteriosus (hsPDA) is a major cause of neonatal morbidity and mortality in extremely low birth weight (ELBW) infants. The optimal management of PDA in these infants is unsettled; however, medical treatment with cyclooxygenases (C...
Saved in:
| Main Author: | Amal Sabouni (17046236) (author) |
|---|---|
| Other Authors: | Ashraf Gad (17040114) (author), Alaa ElMasry (17046276) (author), Fawzia Elghabawy (17046280) (author), Sheikha Alnaimi (17046281) (author) |
| Published: |
2023
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Management of patent ductus arteriosus – Evidence to practice
by: Samir Gupta (584529)
Published: (2024) -
Cost-Effectiveness Analysis of Ibuprofen Versus Indomethacin or Paracetamol for the Treatment of Patent Ductus Arteriosus in Preterm Neonates
by: Samaher Al-Shaibi (14152206)
Published: (2023) -
And the Mountains Echoed: Translation and Commentary
by: Al Hommoud, Yosef
Published: (2014) -
Aspirin inhibition and recovery of cyclooxygenase activity and thromboxane biosynthesis in human megakaryocytes: a translational surrogate model
by: Zahraa I. Mallah (23125621)
Published: (2025) -
Post-discharge outcomes associated with bronchopulmonary dysplasia in extremely low birth weight infants: A retrospective chart review study.
by: Thomas Mathen Maveli (17046295)
Published: (2023)